The BIWS Advanced Financial Modeling Course Will Be Discontinued on March 1st, 2025
On March 1st, 2025, we will remove the current Advanced Modeling course on the site and replace it with 2 shorter, separate courses, with a 3rd separate course to follow in Q2 2025. The current course is too long and detailed for most students, and hardly anyone uses all of it.
If you already have the Advanced course, nothing will change for you. The course will simply not be available for sale to new students anymore.
What does this mean for you?
Sign Up BEFORE March 1st If…
- You want the entire Advanced Modeling course (40+ hours of training), with coverage of advanced accounting, 3-statement modeling, valuation, and merger and LBO models.
- You want the best overall value and the most content for the lowest price.
Sign Up ON OR AFTER March 1st If…
- You would rather pay $200 less for a shorter, more targeted course on one specific topic.
- You only care about certain training, such as biotech valuation or advanced M&A modeling.
Advanced
Financial
Modeling
The current Advanced Financial Modeling Course will be removed and replaced with 3 separate courses:
- Advanced M&A Modeling ($97): Includes intermediate and advanced merger models, a spinoff model, and a majority-stake acquisition. Geared toward experienced bankers. Approximately 10-12 hours of training.
- Biotech Valuation ($97): Includes simplified and more advanced pre-revenue biotech valuations, a “platform biotech” valuation, and an accompanying stock pitch, IB pitch book, and equity research report. Approximately 10 hours of training.
- Advanced Accounting ($97): This will NOT be available on March 1st. In Q2 2025, this course will cover topics such as lease accounting, deferred taxes and NOLs, equity investments and noncontrolling interests, debt accounting, pensions, and more.
Biotech
Valuation Available
March 1, 2025
Advanced
M&A Modeling Available
March 1, 2025
Advanced
Accounting Coming in Q2 2025